Another application for human iPSC-based heart-on-chip platform is the mechanistic investigation of incomplete penetrance in dilated cardiomyopathy caused by titin truncating mutations (Hinson et al., 2015). This evidence concerns the gene TTN and dilated cardiomyopathy.